Drugs / iNKT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07055568 | Sep 2025 → Sep 2027 expected | malignant pancreatic neoplasm | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iNKT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07055568 ↗ |
| Modality | Cell therapy | “Allogeneic iNKT Cell Infusion” NCT07055568 ↗ |
| Route | Intravenous | “Intravenous infusion” NCT07055568 ↗ |